TheĀ HESI Cardiac Safety CommitteeĀ has published a new study in theĀ Journal of Pharmacological and Toxicological MethodsĀ exploring the use of corrected JT-peak (JTpc) and Tpeak-to-Tend (TpTec) intervals as potential biomarkers for assessing drug-induced proarrhythmia risk in nonclinical species.
Assessment of corrected JT-peak (JTpc) and Tpeak-to-Tend (TpTec) as proarrhythmia biomarkers in non-human primates: Outcome from a HESI consortium
Journal of Pharmacological and Toxicological Methods, 2024

